BioCentury | Jan 7, 2016
Translation in Brief

New beginnings

...industry another approach to tackle heart disease. A growing number of companies - including Taxus Cardium...
BioCentury | Jul 23, 2015
Tools & Techniques

Gene therapy's coming of age

...Heart; Liver Phase III Ascend Biopharmaceuticals Ltd.; GenVec Inc. (NASDAQ:GNVC); Novartis AG (NYSE:NVS; SIX:NOVN); Taxus Cardium...
...MultiVir Inc. , Novartis, PNP Therapeutics Inc. , Shenzhen SiBiono GeneTech Co. Ltd. , Taxus Cardium...
BioCentury | May 25, 2015
Company News

Taxus Cardium, Shenzhen Qianhai Taxus Insdustry Capital Management deal

...Taxus Cardium granted Shenzhen the first right to negotiate for an exclusive license to develop and...
...will purchase 15% of Taxus’ Angionetics Inc. subsidiary for $3 million by May 30. Taxus Cardium...
BioCentury | May 4, 2015
Company News

Taxus Cardium, Dr. Reddy’s Laboratories Ltd. deal

...Dr. Reddy’s declined to disclose additional details, and Taxus did not respond to inquiries. Taxus Cardium...
BioCentury | Apr 7, 2015
Company News

Management tracks

...La Jolla Pharmaceutical Co. (NASDAQ:LJPC) hired Dennis Mulroy as CFO. He was CFO at Taxus Cardium...
BioCentury | Feb 16, 2015
Clinical News

Generx cardionovo alferminogene tadenovec: Interim Phase III data

...treated with Generx experienced an improvement in RPDS. The trial is enrolling 100 patients. Taxus Cardium...
BioCentury | Jan 26, 2015
Company News

Taxus Cardium board of directors update

...Taxus Cardium Pharmaceuticals Group Inc. (OTCQB:CRXM), San Diego, Calif. Business: Cardiovascular Appointed: John Wallace, president of...
BioCentury | Apr 7, 2014
Finance

1Q Stock Wrap-Up: Small but mighty

...Moderate to severe Crohn's disease PDUFA date 6/18/14 Taxus Cardium Pharmaceuticals Group Inc. (OTCQB:CRXM) (formerly Cardium Therapeutics Inc....
BioCentury | Mar 24, 2014
Company News

Shanxi Taxus, Taxus Cardium deal

...Cardium Therapeutics Inc. changed its name to Taxus Cardium and partnered with Shanxi Taxus to promote...
...reasonable efforts" to assist Taxus Cardium to develop and refine a plan to commercialize Taxus Cardium's...
...price of Taxus Cardium common stock over the 30-day period prior to each closing. Taxus Cardium...
BioCentury | Mar 6, 2014
Targets & Mechanisms

Heart cells: no longer undivided

...the proliferation of existing cardiomyocytes. Source: BCIQ: BioCentury Online Intelligence Company Product Description Indication(s) Status Cardium Therapeutics Inc....
Items per page:
1 - 10 of 86
BioCentury | Jan 7, 2016
Translation in Brief

New beginnings

...industry another approach to tackle heart disease. A growing number of companies - including Taxus Cardium...
BioCentury | Jul 23, 2015
Tools & Techniques

Gene therapy's coming of age

...Heart; Liver Phase III Ascend Biopharmaceuticals Ltd.; GenVec Inc. (NASDAQ:GNVC); Novartis AG (NYSE:NVS; SIX:NOVN); Taxus Cardium...
...MultiVir Inc. , Novartis, PNP Therapeutics Inc. , Shenzhen SiBiono GeneTech Co. Ltd. , Taxus Cardium...
BioCentury | May 25, 2015
Company News

Taxus Cardium, Shenzhen Qianhai Taxus Insdustry Capital Management deal

...Taxus Cardium granted Shenzhen the first right to negotiate for an exclusive license to develop and...
...will purchase 15% of Taxus’ Angionetics Inc. subsidiary for $3 million by May 30. Taxus Cardium...
BioCentury | May 4, 2015
Company News

Taxus Cardium, Dr. Reddy’s Laboratories Ltd. deal

...Dr. Reddy’s declined to disclose additional details, and Taxus did not respond to inquiries. Taxus Cardium...
BioCentury | Apr 7, 2015
Company News

Management tracks

...La Jolla Pharmaceutical Co. (NASDAQ:LJPC) hired Dennis Mulroy as CFO. He was CFO at Taxus Cardium...
BioCentury | Feb 16, 2015
Clinical News

Generx cardionovo alferminogene tadenovec: Interim Phase III data

...treated with Generx experienced an improvement in RPDS. The trial is enrolling 100 patients. Taxus Cardium...
BioCentury | Jan 26, 2015
Company News

Taxus Cardium board of directors update

...Taxus Cardium Pharmaceuticals Group Inc. (OTCQB:CRXM), San Diego, Calif. Business: Cardiovascular Appointed: John Wallace, president of...
BioCentury | Apr 7, 2014
Finance

1Q Stock Wrap-Up: Small but mighty

...Moderate to severe Crohn's disease PDUFA date 6/18/14 Taxus Cardium Pharmaceuticals Group Inc. (OTCQB:CRXM) (formerly Cardium Therapeutics Inc....
BioCentury | Mar 24, 2014
Company News

Shanxi Taxus, Taxus Cardium deal

...Cardium Therapeutics Inc. changed its name to Taxus Cardium and partnered with Shanxi Taxus to promote...
...reasonable efforts" to assist Taxus Cardium to develop and refine a plan to commercialize Taxus Cardium's...
...price of Taxus Cardium common stock over the 30-day period prior to each closing. Taxus Cardium...
BioCentury | Mar 6, 2014
Targets & Mechanisms

Heart cells: no longer undivided

...the proliferation of existing cardiomyocytes. Source: BCIQ: BioCentury Online Intelligence Company Product Description Indication(s) Status Cardium Therapeutics Inc....
Items per page:
1 - 10 of 86